Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (121-130 of 450) with videos related to

Pageof 45
Sort By:
Free Neuropathology|November 29, 2023
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approachDavid E Reuss, Daniel Schrimpf, Damian Stichel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade GliomaDarren R Hargrave, Keita Terashima, Junichi Hara, et al.
Scientific Reports|May 7, 2020
Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strengthDaniel Schwarz, Asa S Hidmark, Volker Sturm, et al.
Journal of Neuro-Oncology|January 13, 2026
Early distant progression in adult Histone-3 K27-altered diffuse midline gliomasNiklas Grassl, Abigail K Suwala, Tobias Kessler, et al.
Neuro-Oncology Advances|March 27, 2023
Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastomaRiccardo Leone, Hagen Meredig, Martha Foltyn-Dumitru, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 23, 2016
SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literatureRoss Mangum, Elizabeth Varga, Daniel R Boué, et al.
Journal of Neuro-Oncology|April 29, 2020
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytomaMaximilian J Mair, Adelheid Wöhrer, Julia Furtner, et al.
Cancers|April 23, 2022
Outcome after Radiotherapy for Vestibular Schwannomas (VS)-Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton TherapyMaike Küchler, Rami A El Shafie, Sebastian Adeberg, et al.
Acta Neuropathologica|August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningiomaSybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Nature Communications|February 13, 2021
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in gliomaErik Jung, Matthias Osswald, Miriam Ratliff, et al.
Pageof 45

Showing results (121-130 of 450) with videos related to

Sort By:
Pageof 45
Free Neuropathology|November 29, 2023
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approachDavid E Reuss, Daniel Schrimpf, Damian Stichel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade GliomaDarren R Hargrave, Keita Terashima, Junichi Hara, et al.
Scientific Reports|May 7, 2020
Characterization of experimental diabetic neuropathy using multicontrast magnetic resonance neurography at ultra high field strengthDaniel Schwarz, Asa S Hidmark, Volker Sturm, et al.
Journal of Neuro-Oncology|January 13, 2026
Early distant progression in adult Histone-3 K27-altered diffuse midline gliomasNiklas Grassl, Abigail K Suwala, Tobias Kessler, et al.
Neuro-Oncology Advances|March 27, 2023
Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastomaRiccardo Leone, Hagen Meredig, Martha Foltyn-Dumitru, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 23, 2016
SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literatureRoss Mangum, Elizabeth Varga, Daniel R Boué, et al.
Journal of Neuro-Oncology|April 29, 2020
Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytomaMaximilian J Mair, Adelheid Wöhrer, Julia Furtner, et al.
Cancers|April 23, 2022
Outcome after Radiotherapy for Vestibular Schwannomas (VS)-Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton TherapyMaike Küchler, Rami A El Shafie, Sebastian Adeberg, et al.
Acta Neuropathologica|August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningiomaSybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Nature Communications|February 13, 2021
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in gliomaErik Jung, Matthias Osswald, Miriam Ratliff, et al.
Pageof 45